Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
| 28.07 Delayed Data As of Sep 30 |  -0.92 / -3.17%Today’s Change | 18.12 Today|||52-Week Range 44.46 | +20.52% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 251.5M | 255.2M | 240.2M | 294.7M | |
| Cost of Goods Sold | 164.7M | 141.1M | 138.9M | 176.5M | ||
| Depreciation And Amortization | 13.3M | 14.6M | 15.4M | 16.5M | ||
| Operating Expenses | Gross Income | 73.6M | 99.5M | 85.8M | 101.7M | |
| General Expenses | 76.9M | 83.8M | 89.4M | 110.3M | ||
| Research And Development | 33.3M | 36.5M | 38.5M | 52.4M | ||
| Total Operating Expenses | 254.9M | 239.5M | 243.7M | 303.3M | ||
| Non-Operating Expenses | Operating Income | -3.4M | 15.7M | -3.5M | -8.6M | |
| Extraordinary Charge | -3.5M | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 2.1M | 1.8M | 2.0M | 2.4M | ||
| Other Expenses | -2.8M | 8.0K | 5.6M | -1.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -10.4M | 14.9M | 1.6M | -9.9M | |
| Income Taxes | -7.6M | -4.4M | -2.9M | -3.3M | ||
| Minority Interest | 0.00 | 0.00 | 0.00 | -922.0K | ||
| Net Income | -2.8M | 10.5M | 4.5M | -5.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 45.0M | 45.4M | 46.1M | 46.4M | |
| Shares To Calculate EPS Diluted | 45.0M | 47.5M | 48.4M | 46.4M | ||
| Earnings Per Share | EPS | -$0.06 | $0.22 | $0.09 | -$0.12 | |
| EPS Diluted | -$0.06 | $0.22 | $0.09 | -$0.12 | ||
